1297ORandomized results of fixed-duration (1-yr) vs continuous nivolumab in patients (pts) with advanced non-small cell lung cancer (NSCLC)
Spigel, D.R., McLeod, M., Hussein, M.A., Waterhouse, D.M., Einhorn, L., Horn, L., Creelan, B., Babu, S., Leighl, N.B., Couture, F., Chandler, J., Goss, G., Keogh, G., Garon, E.B., Blankstein, K.B., DaVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx380.002
Date:
September, 2017
File:
PDF, 50 KB
english, 2017